Qiagen's forward-looking non-GAAP guidance lacked required GAAP reconciliations under SEC Regulation S-K Item 10(e) -- institutional investors who relied on these figures for portfolio allocation decisions...
The law firm of Kirby McInerney LLP is investigating potential claims against Qiagen N.V. (“Qiagen” or the “Company”) (NYSE:QGEN). The investigation concerns whether the Company...
Co-founder and former CEO Dr. Metin Colpan to become Honorary Chairman of the Supervisory Board after deciding not to stand for re-election ...
New York, New York--(Newsfile Corp. - May 11, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Qiagen N.V. (NYSE: QGEN) ("Qiagen N.V.") concerning potential violations...
Ambition to support high-throughput laboratories in efficiently scaling latent tuberculosis (TB) screening as testing volumes continue to grow ...
New York, New York--(Newsfile Corp. - May 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Qiagen N.V. ("Qiagen N.V.") (NYSE: QGEN) concerning potential violations...
Q1 2026 results in line with pre-announcement: Net sales rise 2% to $492 million on a reported basis, and -1% at constant exchange rates...
Qiagen projected a low single digit rate first-quarter QuantiFERON growth rate on February 5, 2026. Actual Q1 2026 volumes showed a 5% decline
Barchart Research What to Expect from QGEN Earnings QGEN Generated May 5, 2026 Current Price $34.00 EPS Estimate $$0.54 Consensus Rating Moderate Buy Average Move 1.75% Qiagen's Immigration Testing Problem:...
New York, New York--(Newsfile Corp. - April 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Qiagen N.V. ("Qiagen N.V.") (NYSE: QGEN) concerning potential violations...